Senate Bill 3257
117th Congress(2021-2022)
A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.
Introduced
Introduced in Senate on Nov 18, 2021
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3257
Congress
117
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
No Senate votes have been held for this bill.
Summary
This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy. Additionally, the bill revises the process by which the Department of Justice may modify the number of days within which such drugs must be administered.
November 18, 2021
Sort by most recent
11/18/2021
Read twice and referred to the Committee on the Judiciary.
11/18/2021
Introduced in Senate
Public Record
Record Updated
Sep 12, 2023 2:00:29 PM